Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Carolina Martinez‐Ciarpaglini"'
Autor:
Carolina Martinez-Ciarpaglini, Daniela S Thommen, Nicole C T van Grieken, Joep Grootjans, Sarah Derks, Tessa S Groen-van Schooten, Rosalia Franco Fernandez, Emma N Bos, Jens Seidel, Job Saris, Tania C Fleitas
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 12, Iss 7 (2024)
Background Tertiary lymphoid structures (TLSs) are thought to stimulate antitumor immunity and positively impact prognosis and response to immune checkpoint blockade. In gastric cancers (GCs), however, TLSs are predominantly found in GC with poor pro
Externí odkaz:
https://doaj.org/article/785d4f4c841145b58d42944ccbc30db0
Autor:
Jenniffer Linares, Anna Sallent-Aragay, Jordi Badia-Ramentol, Alba Recort-Bascuas, Ana Méndez, Noemí Manero-Rupérez, Daniele Lo Re, Elisa I. Rivas, Marc Guiu, Melissa Zwick, Mar Iglesias, Carolina Martinez-Ciarpaglini, Noelia Tarazona, Monica Varese, Xavier Hernando-Momblona, Adrià Cañellas-Socias, Mayra Orrillo, Marta Garrido, Nadia Saoudi, Elena Elez, Pilar Navarro, Josep Tabernero, Roger R. Gomis, Eduard Batlle, Jorge Pisonero, Andres Cervantes, Clara Montagut, Alexandre Calon
Publikováno v:
Nature Communications, Vol 14, Iss 1, Pp 1-18 (2023)
Standard platinum-based chemotherapy is the basis of treatment of many cancers, however a proportion of patients do not derive benefit. Here the authors show that the platinum-based drug oxaliplatin accumulates in cancer-associated fibroblasts, activ
Externí odkaz:
https://doaj.org/article/6c73f8461c124a2ba8d43e933f393b91
Autor:
Federica Papaccio, Blanca García-Mico, Francisco Gimeno-Valiente, Manuel Cabeza-Segura, Valentina Gambardella, María Fernanda Gutiérrez-Bravo, Clara Alfaro-Cervelló, Carolina Martinez-Ciarpaglini, Pilar Rentero-Garrido, Sheila Zúñiga-Trejos, Juan Antonio Carbonell-Asins, Tania Fleitas, Susana Roselló, Marisol Huerta, Manuel M. Sánchez del Pino, Luís Sabater, Desamparados Roda, Noelia Tarazona, Andrés Cervantes, Josefa Castillo
Publikováno v:
Journal of Experimental & Clinical Cancer Research, Vol 42, Iss 1, Pp 1-22 (2023)
Abstract Background Patient-derived organoids (PDOs) from advanced colorectal cancer (CRC) patients could be a key platform to predict drug response and discover new biomarkers. We aimed to integrate PDO drug response with multi-omics characterizatio
Externí odkaz:
https://doaj.org/article/a72cfc5ee59741f4839fb4407bd9b3b0
Molecular profile in Paraguayan colorectal cancer patients, towards to a precision medicine strategy
Autor:
Tania Fleitas-Kanonnikoff, Carolina Martinez‐Ciarpaglini, Josefina Ayala, Cinthia Gauna, Rita Denis, Ita Yoffe, Silvia Sforza, María Teresa Martínez, Alicia Pomata, Maider Ibarrola‐Villava, Sipan Arevshatyan, Verónica Burriel, Diego Boscá, Oscar Pastor, Ana Ferrer‐Martinez, Francisca Carrasco, Cristina Mongort, Samuel Navarro, Gloria Ribas, Andres Cervantes
Publikováno v:
Cancer Medicine, Vol 8, Iss 6, Pp 3120-3130 (2019)
Abstract Somatic mutation analysis and evaluation of microsatellite instability (MSI) have become mandatory for selecting personalized therapy strategies for advanced colorectal cancer and are not available as routine methods in Paraguay. The aims of
Externí odkaz:
https://doaj.org/article/c4ab06011a3946a985a944f3fdd2eacb
Autor:
Valentina Gambardella, Andrés Cervantes, Elisa Fontana, Katherine Eason, Anguraj Sadanandam, Carolina Martinez-Ciarpaglini, Marisol Huerta, Susana Rosello, Desamparados Roda, Noelia Tarazona, Federica Papaccio, Francisco Gimeno-Valiente, Sheila Zuniga, Alexandre Calon, Juan Antonio Carbonell-Asins, Pilar Rentero-Garrido, Tania Fleitas, David Moro-Valdezate, Gift Nyamundanda, Josefa Castillo, Alejandro Espí
Publikováno v:
ESMO Open, Vol 5, Iss 5 (2020)
Background Colon cancer (CC) is a heterogeneous disease. Novel prognostic factors beyond pathological staging are required to accurately identify patients at higher risk of relapse. Integrating these new biological factors, such as plasma circulating
Externí odkaz:
https://doaj.org/article/1ba9bbd5d5ea42709d18d95be914965b
Autor:
Valentina Gambardella, Andrés Cervantes, Carolina Martinez-Ciarpaglini, Tania Fleitas-Kanonnikoff, Marta Llorca, Cristina Mongort, Regina Mengual, Gema Nieto, Lara Navarro, Marisol Huerta, Susana Rosello, Desamparados Roda, Samuel Navarro, Gloria Ribas
Publikováno v:
ESMO Open, Vol 4, Iss 3 (2019)
Background The molecular classification of gastric cancer recognises two subtypes prone to immune checkpoint blockade: the microsatellite unstable and the Epstein-Barr virus (EBV)-related tumours. We aim to assess the concordance between immunohistoc
Externí odkaz:
https://doaj.org/article/55466a2d21174801b8184ccba03bab4c
Autor:
Andrés Cervantes, Josefa Castillo, Susana Roselló, Marisol Huerta, Juan Miguel Cejalvo, Pablo Tolosa, Tania Fleitas, Desamparados Roda, Carolina Martinez Ciarpaglini, Noelia Tarazona, Francisco Gimeno-Valiente, Valentina Gambardella
Primers obtained from PrimerBank database.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::611b7a7ee09ed1ad54389f79e7cd43d8
https://doi.org/10.1158/1078-0432.22471488.v1
https://doi.org/10.1158/1078-0432.22471488.v1
Autor:
Andrés Cervantes, Josefa Castillo, Susana Roselló, Marisol Huerta, Juan Miguel Cejalvo, Pablo Tolosa, Tania Fleitas, Desamparados Roda, Carolina Martinez Ciarpaglini, Noelia Tarazona, Francisco Gimeno-Valiente, Valentina Gambardella
NRF2 expression analysed by Western Blot after subcellular fractionation.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2b8bdcbda32fd416f51e7aac2fddad8e
https://doi.org/10.1158/1078-0432.22471494
https://doi.org/10.1158/1078-0432.22471494
Autor:
Andrés Cervantes, Josefa Castillo, Susana Roselló, Marisol Huerta, Juan Miguel Cejalvo, Pablo Tolosa, Tania Fleitas, Desamparados Roda, Carolina Martinez Ciarpaglini, Noelia Tarazona, Francisco Gimeno-Valiente, Valentina Gambardella
Purpose:Despite the clinical advantage of the combination of trastuzumab and platinum-based chemotherapy in HER2-amplified tumors, resistance will eventually develop. The identification of molecular mechanisms related to primary and acquired resistan
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7fb24318b432c5549dbd90e52dd22da8
https://doi.org/10.1158/1078-0432.c.6527910
https://doi.org/10.1158/1078-0432.c.6527910
Autor:
Carolina Martinez Ciarpaglini, F. Gimeno-Valiente, Valentina Gambardella, Josefa Castillo, Desamparados Roda, Andrés Cervantes, Susana Roselló, P. Tolosa, Juan Miguel Cejalvo, Marisol Huerta, Noelia Tarazona, T. Fleitas
Publikováno v:
Clinical Cancer Research. 25:1639-1649
Purpose: Despite the clinical advantage of the combination of trastuzumab and platinum-based chemotherapy in HER2-amplified tumors, resistance will eventually develop. The identification of molecular mechanisms related to primary and acquired resista